Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Endometrial SPOREs

Endometrial cancer starts in the cells of the inner lining of the uterus (the endometrium) and is the most common type of cancer in the uterus. It is typically diagnosed in women aged 45-74. The death rate from specifically aggressive non-endometrioid subtypes increased by 2.7% each year from 2010-2017, with the worst outcomes in black women. The American Cancer Society (ACS) forecasts approximately 69,120 new cases and 13,860 deaths for 2025.  The first Endometrial Specialized Programs of Research Excellence (SPORE) was funded in 2003.

Washington University Endometrial SPORE

  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Endometrial SPOREs was originally published by the National Cancer Institute.”

Email